ENALAPRIL (MK-421), A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - ACUTE AND CHRONIC EFFECTS IN HEART-FAILURE

被引：20
|
作者：
DUNKMAN, WB
WILEN, M
FRANCIOSA, JA
机构：
[1] VET ADM MED CTR,CARDIOVASC SECT,PHILADELPHIA,PA 19104
[2] HOSP UNIV PENN,PHILADELPHIA,PA 19104
来源：
CHEST | 1983年 / 84卷 / 05期
关键词：
D O I：
10.1378/chest.84.5.539
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：539 / 545
页数：7
相关论文
共 50 条
  • [1] ENALAPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN CHRONIC HEART-FAILURE - ACUTE AND CHRONIC HEMODYNAMIC EVALUATIONS
    DICARLO, L
    CHATTERJEE, K
    PARMLEY, WW
    SWEDBERG, K
    ATHERTON, B
    CURRAN, D
    CUCCI, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 2 (05) : 865 - 871
  • [2] EFFECTS OF A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, MK-421, IN NORMAL MEN AND PATIENTS
    KONO, T
    OSEKO, F
    IKEDA, F
    NAKANO, R
    TANIGUCHI, A
    IMURA, H
    ENDO, J
    ENDOCRINOLOGIA JAPONICA, 1982, 29 (05): : 615 - 622
  • [3] MK-421 - A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN CHRONIC HEART-FAILURE - NEUROHUMORAL CORRELATES OF THE HEMODYNAMIC-RESPONSE TO ACUTE AND CHRONIC THERAPY
    DICARLO, L
    CHATTERJEE, K
    ATHERTON, B
    CURRAN, D
    PARMLEY, W
    CLINICAL RESEARCH, 1983, 31 (02): : A179 - A179
  • [4] EFFECTS OF THE ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION
    GAVRAS, H
    BIOLLAZ, J
    WAEBER, B
    BRUNNER, HR
    GAVRAS, I
    SACKEL, H
    CHAROCOPOS, F
    DAVIES, RO
    CLINICAL SCIENCE, 1981, 61 : S281 - S283
  • [5] MK 421 - A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN CHRONIC HEART-FAILURE - ACUTE AND CHRONIC HEMODYNAMIC-RESPONSE
    DICARLO, L
    CHATTERJEE, K
    SWEDBERG, K
    ATHERTON, B
    CURRAN, D
    PARMLEY, W
    CIRCULATION, 1982, 66 (04) : 209 - 209
  • [6] EFFECTS OF ENALAPRIL, A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IN A CONTROLLED TRIAL IN HEART-FAILURE
    FRANCIOSA, JA
    WILEN, MM
    JORDAN, RA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (01) : 101 - 107
  • [7] EFFECTS OF ENALAPRIL, A NEW CONVERTING ENZYME-INHIBITOR, IN CHRONIC HEART-FAILURE
    FRANCIOSA, JA
    DUNKMAN, WB
    WILEN, M
    HANSELL, JR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 205 - 205
  • [8] PHARMACOLOGICAL PROPERTIES OF THE CONVERTING ENZYME-INHIBITOR, ENALAPRIL MALEATE (MK-421)
    SWEET, CS
    FEDERATION PROCEEDINGS, 1983, 42 (02) : 167 - 170
  • [9] EFFECTS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION
    GAVRAS, H
    BIOLLAZ, J
    WAEBER, B
    BRUNNER, HR
    GAVRAS, I
    DAVIES, RO
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1982, 4 (1-2) : 303 - 314
  • [10] EFFECTS IN HEALTHY-SUBJECTS OF A NEW NON-THIOL-CONTAINING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, ENALAPRIL MALEATE (MK-421)
    NAKASHIMA, M
    NISHIJIMA, K
    CLINICAL SCIENCE, 1982, 63 : S183 - S185
12345